Evolva appoints Jessica Mann as Chief Medical Officer

29-Oct-2009 - Switzerland

Evolva SA has expanded its management team by appointing Jessica Mann as Chief Medical Officer. She has supported Evolva as an advisor over the last year and has been actively involved in the clinical development of Evolva’s compound portfolio in this period.

Jessica Mann, MD, PhD has long-standing experience in drug development; she was previously Medical Director and a member of the management group of Speedel AG (sold to Novartis for USD 880 million in 2008) and prior to that worked at Roche, where she was a Senior Clinical and Licensing Liaison, and Novartis, where she was International Clinical Leader for DiovanTM. Before joining Novartis she was a Lecturer in Cardiovascular Pathology at St George’s Hospital Medical School in London. Jessica has an MD from the University of Buenos Aires and a PhD from the University of London.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances